 | • レポートコード：MRC2-11QY01128 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はC型肝炎ウイルスエンベロープタンパク質E2のグローバル市場について調査・分析したレポートです。種類別（E-20、MBL-HCV-1、CIGB-230、BTA-074、その他）市場規模、用途別（C型肝炎、性器いぼ、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別C型肝炎ウイルスエンベロープタンパク質E2の競争状況、市場シェア ・世界のC型肝炎ウイルスエンベロープタンパク質E2市場：種類別市場規模 2015年-2020年（E-20、MBL-HCV-1、CIGB-230、BTA-074、その他） ・世界のC型肝炎ウイルスエンベロープタンパク質E2市場：種類別市場規模予測 2021年-2026年（E-20、MBL-HCV-1、CIGB-230、BTA-074、その他） ・世界のC型肝炎ウイルスエンベロープタンパク質E2市場：用途別市場規模 2015年-2020年（C型肝炎、性器いぼ、その他） ・世界のC型肝炎ウイルスエンベロープタンパク質E2市場：用途別市場規模予測 2021年-2026年（C型肝炎、性器いぼ、その他） ・北米のC型肝炎ウイルスエンベロープタンパク質E2市場分析：米国、カナダ ・ヨーロッパのC型肝炎ウイルスエンベロープタンパク質E2市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのC型肝炎ウイルスエンベロープタンパク質E2市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のC型肝炎ウイルスエンベロープタンパク質E2市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのC型肝炎ウイルスエンベロープタンパク質E2市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aviragen Therapeutics Inc、Integrated BioTherapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Hepatitis C Virus Envelope Protein E2 Market
The global Hepatitis C Virus Envelope Protein E2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hepatitis C Virus Envelope Protein E2 Scope and Market Size
Hepatitis C Virus Envelope Protein E2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis C Virus Envelope Protein E2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hepatitis C Virus Envelope Protein E2 market is segmented into
E-20
MBL-HCV-1
CIGB-230
BTA-074
Others
Segment by Application, the Hepatitis C Virus Envelope Protein E2 market is segmented into
Hepatitis C
Genital Warts
Others
Regional and Country-level Analysis
The Hepatitis C Virus Envelope Protein E2 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hepatitis C Virus Envelope Protein E2 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hepatitis C Virus Envelope Protein E2 Market Share Analysis
Hepatitis C Virus Envelope Protein E2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hepatitis C Virus Envelope Protein E2 business, the date to enter into the Hepatitis C Virus Envelope Protein E2 market, Hepatitis C Virus Envelope Protein E2 product introduction, recent developments, etc.
The major vendors covered:
Aviragen Therapeutics Inc
Integrated BioTherapeutics Inc
…
1 Study Coverage
1.1 Hepatitis C Virus Envelope Protein E2 Product Introduction
1.2 Market Segments
1.3 Key Hepatitis C Virus Envelope Protein E2 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hepatitis C Virus Envelope Protein E2 Market Size Growth Rate by Type
1.4.2 E-20
1.4.3 MBL-HCV-1
1.4.4 CIGB-230
1.4.5 BTA-074
1.4.6 Others
1.5 Market by Application
1.5.1 Global Hepatitis C Virus Envelope Protein E2 Market Size Growth Rate by Application
1.5.2 Hepatitis C
1.5.3 Genital Warts
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hepatitis C Virus Envelope Protein E2 Market Size, Estimates and Forecasts
2.1.1 Global Hepatitis C Virus Envelope Protein E2 Revenue 2015-2026
2.1.2 Global Hepatitis C Virus Envelope Protein E2 Sales 2015-2026
2.2 Global Hepatitis C Virus Envelope Protein E2, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hepatitis C Virus Envelope Protein E2 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hepatitis C Virus Envelope Protein E2 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hepatitis C Virus Envelope Protein E2 Competitor Landscape by Players
3.1 Hepatitis C Virus Envelope Protein E2 Sales by Manufacturers
3.1.1 Hepatitis C Virus Envelope Protein E2 Sales by Manufacturers (2015-2020)
3.1.2 Hepatitis C Virus Envelope Protein E2 Sales Market Share by Manufacturers (2015-2020)
3.2 Hepatitis C Virus Envelope Protein E2 Revenue by Manufacturers
3.2.1 Hepatitis C Virus Envelope Protein E2 Revenue by Manufacturers (2015-2020)
3.2.2 Hepatitis C Virus Envelope Protein E2 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hepatitis C Virus Envelope Protein E2 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hepatitis C Virus Envelope Protein E2 Revenue in 2019
3.2.5 Global Hepatitis C Virus Envelope Protein E2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hepatitis C Virus Envelope Protein E2 Price by Manufacturers
3.4 Hepatitis C Virus Envelope Protein E2 Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis C Virus Envelope Protein E2 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis C Virus Envelope Protein E2 Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis C Virus Envelope Protein E2 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hepatitis C Virus Envelope Protein E2 Market Size by Type (2015-2020)
4.1.1 Global Hepatitis C Virus Envelope Protein E2 Sales by Type (2015-2020)
4.1.2 Global Hepatitis C Virus Envelope Protein E2 Revenue by Type (2015-2020)
4.1.3 Hepatitis C Virus Envelope Protein E2 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hepatitis C Virus Envelope Protein E2 Market Size Forecast by Type (2021-2026)
4.2.1 Global Hepatitis C Virus Envelope Protein E2 Sales Forecast by Type (2021-2026)
4.2.2 Global Hepatitis C Virus Envelope Protein E2 Revenue Forecast by Type (2021-2026)
4.2.3 Hepatitis C Virus Envelope Protein E2 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hepatitis C Virus Envelope Protein E2 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hepatitis C Virus Envelope Protein E2 Market Size by Application (2015-2020)
5.1.1 Global Hepatitis C Virus Envelope Protein E2 Sales by Application (2015-2020)
5.1.2 Global Hepatitis C Virus Envelope Protein E2 Revenue by Application (2015-2020)
5.1.3 Hepatitis C Virus Envelope Protein E2 Price by Application (2015-2020)
5.2 Hepatitis C Virus Envelope Protein E2 Market Size Forecast by Application (2021-2026)
5.2.1 Global Hepatitis C Virus Envelope Protein E2 Sales Forecast by Application (2021-2026)
5.2.2 Global Hepatitis C Virus Envelope Protein E2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Hepatitis C Virus Envelope Protein E2 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hepatitis C Virus Envelope Protein E2 by Country
6.1.1 North America Hepatitis C Virus Envelope Protein E2 Sales by Country
6.1.2 North America Hepatitis C Virus Envelope Protein E2 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Type
6.3 North America Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Application
7 Europe
7.1 Europe Hepatitis C Virus Envelope Protein E2 by Country
7.1.1 Europe Hepatitis C Virus Envelope Protein E2 Sales by Country
7.1.2 Europe Hepatitis C Virus Envelope Protein E2 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Type
7.3 Europe Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hepatitis C Virus Envelope Protein E2 by Region
8.1.1 Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales by Region
8.1.2 Asia Pacific Hepatitis C Virus Envelope Protein E2 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Type
8.3 Asia Pacific Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hepatitis C Virus Envelope Protein E2 by Country
9.1.1 Latin America Hepatitis C Virus Envelope Protein E2 Sales by Country
9.1.2 Latin America Hepatitis C Virus Envelope Protein E2 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Type
9.3 Central & South America Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis C Virus Envelope Protein E2 by Country
10.1.1 Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales by Country
10.1.2 Middle East and Africa Hepatitis C Virus Envelope Protein E2 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Type
10.3 Middle East and Africa Hepatitis C Virus Envelope Protein E2 Market Facts & Figures by Application
11 Company Profiles
11.1 Aviragen Therapeutics Inc
11.1.1 Aviragen Therapeutics Inc Corporation Information
11.1.2 Aviragen Therapeutics Inc Description and Business Overview
11.1.3 Aviragen Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aviragen Therapeutics Inc Hepatitis C Virus Envelope Protein E2 Products Offered
11.1.5 Aviragen Therapeutics Inc Related Developments
11.2 Integrated BioTherapeutics Inc
11.2.1 Integrated BioTherapeutics Inc Corporation Information
11.2.2 Integrated BioTherapeutics Inc Description and Business Overview
11.2.3 Integrated BioTherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Integrated BioTherapeutics Inc Hepatitis C Virus Envelope Protein E2 Products Offered
11.2.5 Integrated BioTherapeutics Inc Related Developments
11.1 Aviragen Therapeutics Inc
11.1.1 Aviragen Therapeutics Inc Corporation Information
11.1.2 Aviragen Therapeutics Inc Description and Business Overview
11.1.3 Aviragen Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aviragen Therapeutics Inc Hepatitis C Virus Envelope Protein E2 Products Offered
11.1.5 Aviragen Therapeutics Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hepatitis C Virus Envelope Protein E2 Market Estimates and Projections by Region
12.1.1 Global Hepatitis C Virus Envelope Protein E2 Sales Forecast by Regions 2021-2026
12.1.2 Global Hepatitis C Virus Envelope Protein E2 Revenue Forecast by Regions 2021-2026
12.2 North America Hepatitis C Virus Envelope Protein E2 Market Size Forecast (2021-2026)
12.2.1 North America: Hepatitis C Virus Envelope Protein E2 Sales Forecast (2021-2026)
12.2.2 North America: Hepatitis C Virus Envelope Protein E2 Revenue Forecast (2021-2026)
12.2.3 North America: Hepatitis C Virus Envelope Protein E2 Market Size Forecast by Country (2021-2026)
12.3 Europe Hepatitis C Virus Envelope Protein E2 Market Size Forecast (2021-2026)
12.3.1 Europe: Hepatitis C Virus Envelope Protein E2 Sales Forecast (2021-2026)
12.3.2 Europe: Hepatitis C Virus Envelope Protein E2 Revenue Forecast (2021-2026)
12.3.3 Europe: Hepatitis C Virus Envelope Protein E2 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hepatitis C Virus Envelope Protein E2 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hepatitis C Virus Envelope Protein E2 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hepatitis C Virus Envelope Protein E2 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hepatitis C Virus Envelope Protein E2 Market Size Forecast by Region (2021-2026)
12.5 Latin America Hepatitis C Virus Envelope Protein E2 Market Size Forecast (2021-2026)
12.5.1 Latin America: Hepatitis C Virus Envelope Protein E2 Sales Forecast (2021-2026)
12.5.2 Latin America: Hepatitis C Virus Envelope Protein E2 Revenue Forecast (2021-2026)
12.5.3 Latin America: Hepatitis C Virus Envelope Protein E2 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hepatitis C Virus Envelope Protein E2 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hepatitis C Virus Envelope Protein E2 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hepatitis C Virus Envelope Protein E2 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hepatitis C Virus Envelope Protein E2 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hepatitis C Virus Envelope Protein E2 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis C Virus Envelope Protein E2 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hepatitis C Virus Envelope Protein E2 Market Segments
Table 2. Ranking of Global Top Hepatitis C Virus Envelope Protein E2 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hepatitis C Virus Envelope Protein E2 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of E-20
Table 5. Major Manufacturers of MBL-HCV-1
Table 6. Major Manufacturers of CIGB-230
Table 7. Major Manufacturers of BTA-074
Table 8. Major Manufacturers of Others
Table 9. Global Hepatitis C Virus Envelope Protein E2 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Hepatitis C Virus Envelope Protein E2 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Hepatitis C Virus Envelope Protein E2 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share by Regions (2015-2020)
Table 13. Global Hepatitis C Virus Envelope Protein E2 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Hepatitis C Virus Envelope Protein E2 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Hepatitis C Virus Envelope Protein E2 Sales Share by Manufacturers (2015-2020)
Table 16. Global Hepatitis C Virus Envelope Protein E2 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Hepatitis C Virus Envelope Protein E2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Virus Envelope Protein E2 as of 2019)
Table 18. Hepatitis C Virus Envelope Protein E2 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Hepatitis C Virus Envelope Protein E2 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Hepatitis C Virus Envelope Protein E2 Price (2015-2020) (USD/Pcs)
Table 21. Hepatitis C Virus Envelope Protein E2 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hepatitis C Virus Envelope Protein E2 Product Type
Table 23. Date of International Manufacturers Enter into Hepatitis C Virus Envelope Protein E2 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Hepatitis C Virus Envelope Protein E2 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Hepatitis C Virus Envelope Protein E2 Sales Share by Type (2015-2020)
Table 27. Global Hepatitis C Virus Envelope Protein E2 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Hepatitis C Virus Envelope Protein E2 Revenue Share by Type (2015-2020)
Table 29. Hepatitis C Virus Envelope Protein E2 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Hepatitis C Virus Envelope Protein E2 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Hepatitis C Virus Envelope Protein E2 Sales Share by Application (2015-2020)
Table 32. North America Hepatitis C Virus Envelope Protein E2 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Hepatitis C Virus Envelope Protein E2 Sales Market Share by Country (2015-2020)
Table 34. North America Hepatitis C Virus Envelope Protein E2 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Country (2015-2020)
Table 36. North America Hepatitis C Virus Envelope Protein E2 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Hepatitis C Virus Envelope Protein E2 Sales Market Share by Type (2015-2020)
Table 38. North America Hepatitis C Virus Envelope Protein E2 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Hepatitis C Virus Envelope Protein E2 Sales Market Share by Application (2015-2020)
Table 40. Europe Hepatitis C Virus Envelope Protein E2 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Hepatitis C Virus Envelope Protein E2 Sales Market Share by Country (2015-2020)
Table 42. Europe Hepatitis C Virus Envelope Protein E2 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Country (2015-2020)
Table 44. Europe Hepatitis C Virus Envelope Protein E2 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Hepatitis C Virus Envelope Protein E2 Sales Market Share by Type (2015-2020)
Table 46. Europe Hepatitis C Virus Envelope Protein E2 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Hepatitis C Virus Envelope Protein E2 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Hepatitis C Virus Envelope Protein E2 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales Market Share by Application (2015-2020)
Table 56. Latin America Hepatitis C Virus Envelope Protein E2 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Hepatitis C Virus Envelope Protein E2 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Hepatitis C Virus Envelope Protein E2 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Hepatitis C Virus Envelope Protein E2 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Hepatitis C Virus Envelope Protein E2 Sales Market Share by Type (2015-2020)
Table 62. Latin America Hepatitis C Virus Envelope Protein E2 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Hepatitis C Virus Envelope Protein E2 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales Market Share by Application (2015-2020)
Table 72. Aviragen Therapeutics Inc Corporation Information
Table 73. Aviragen Therapeutics Inc Description and Major Businesses
Table 74. Aviragen Therapeutics Inc Hepatitis C Virus Envelope Protein E2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Aviragen Therapeutics Inc Product
Table 76. Aviragen Therapeutics Inc Recent Development
Table 77. Integrated BioTherapeutics Inc Corporation Information
Table 78. Integrated BioTherapeutics Inc Description and Major Businesses
Table 79. Integrated BioTherapeutics Inc Hepatitis C Virus Envelope Protein E2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Integrated BioTherapeutics Inc Product
Table 81. Integrated BioTherapeutics Inc Recent Development
Table 82. Global Hepatitis C Virus Envelope Protein E2 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 83. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share Forecast by Regions (2021-2026)
Table 84. Global Hepatitis C Virus Envelope Protein E2 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 85. Global Hepatitis C Virus Envelope Protein E2 Revenue Market Share Forecast by Regions (2021-2026)
Table 86. North America: Hepatitis C Virus Envelope Protein E2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 87. North America: Hepatitis C Virus Envelope Protein E2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 88. Europe: Hepatitis C Virus Envelope Protein E2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 89. Europe: Hepatitis C Virus Envelope Protein E2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 90. Asia Pacific: Hepatitis C Virus Envelope Protein E2 Sales Forecast by Region (2021-2026) (K Pcs)
Table 91. Asia Pacific: Hepatitis C Virus Envelope Protein E2 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 92. Latin America: Hepatitis C Virus Envelope Protein E2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 93. Latin America: Hepatitis C Virus Envelope Protein E2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 94. Middle East and Africa: Hepatitis C Virus Envelope Protein E2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 95. Middle East and Africa: Hepatitis C Virus Envelope Protein E2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 96. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 97. Key Challenges
Table 98. Market Risks
Table 99. Main Points Interviewed from Key Hepatitis C Virus Envelope Protein E2 Players
Table 100. Hepatitis C Virus Envelope Protein E2 Customers List
Table 101. Hepatitis C Virus Envelope Protein E2 Distributors List
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis C Virus Envelope Protein E2 Product Picture
Figure 2. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share by Type in 2020 & 2026
Figure 3. E-20 Product Picture
Figure 4. MBL-HCV-1 Product Picture
Figure 5. CIGB-230 Product Picture
Figure 6. BTA-074 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share by Application in 2020 & 2026
Figure 9. Hepatitis C
Figure 10. Genital Warts
Figure 11. Others
Figure 12. Hepatitis C Virus Envelope Protein E2 Report Years Considered
Figure 13. Global Hepatitis C Virus Envelope Protein E2 Market Size 2015-2026 (US$ Million)
Figure 14. Global Hepatitis C Virus Envelope Protein E2 Sales 2015-2026 (K Pcs)
Figure 15. Global Hepatitis C Virus Envelope Protein E2 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share by Region (2015-2020)
Figure 17. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share by Region in 2019
Figure 18. Global Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Region (2015-2020)
Figure 19. Global Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Region in 2019
Figure 20. Global Hepatitis C Virus Envelope Protein E2 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Hepatitis C Virus Envelope Protein E2 Revenue in 2019
Figure 22. Hepatitis C Virus Envelope Protein E2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share by Type (2015-2020)
Figure 24. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share by Type in 2019
Figure 25. Global Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Type (2015-2020)
Figure 26. Global Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Type in 2019
Figure 27. Global Hepatitis C Virus Envelope Protein E2 Market Share by Price Range (2015-2020)
Figure 28. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share by Application (2015-2020)
Figure 29. Global Hepatitis C Virus Envelope Protein E2 Sales Market Share by Application in 2019
Figure 30. Global Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Application (2015-2020)
Figure 31. Global Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Application in 2019
Figure 32. North America Hepatitis C Virus Envelope Protein E2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Hepatitis C Virus Envelope Protein E2 Sales Market Share by Country in 2019
Figure 35. North America Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Country in 2019
Figure 36. U.S. Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Hepatitis C Virus Envelope Protein E2 Market Share by Type in 2019
Figure 41. North America Hepatitis C Virus Envelope Protein E2 Market Share by Application in 2019
Figure 42. Europe Hepatitis C Virus Envelope Protein E2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Hepatitis C Virus Envelope Protein E2 Sales Market Share by Country in 2019
Figure 45. Europe Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Country in 2019
Figure 46. Germany Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Hepatitis C Virus Envelope Protein E2 Market Share by Type in 2019
Figure 57. Europe Hepatitis C Virus Envelope Protein E2 Market Share by Application in 2019
Figure 58. Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales Market Share by Region in 2019
Figure 61. Asia Pacific Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Region in 2019
Figure 62. China Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Hepatitis C Virus Envelope Protein E2 Market Share by Type in 2019
Figure 85. Asia Pacific Hepatitis C Virus Envelope Protein E2 Market Share by Application in 2019
Figure 86. Latin America Hepatitis C Virus Envelope Protein E2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Hepatitis C Virus Envelope Protein E2 Sales Market Share by Country in 2019
Figure 89. Latin America Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Country in 2019
Figure 90. Mexico Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Hepatitis C Virus Envelope Protein E2 Market Share by Type in 2019
Figure 97. Latin America Hepatitis C Virus Envelope Protein E2 Market Share by Application in 2019
Figure 98. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Revenue Market Share by Country in 2019
Figure 102. Turkey Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Hepatitis C Virus Envelope Protein E2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Market Share by Type in 2019
Figure 109. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Market Share by Application in 2019
Figure 110. North America Hepatitis C Virus Envelope Protein E2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Hepatitis C Virus Envelope Protein E2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Hepatitis C Virus Envelope Protein E2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Hepatitis C Virus Envelope Protein E2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Hepatitis C Virus Envelope Protein E2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…- C型肝炎ウイルス（HCV）の世界市場（～2026年） Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…
- C型肝炎ウイルス（HCV）抗ウイルス剤の世界市場（～2026年） Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatit…
- A型肝炎ウイルス細胞受容体2の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis A Virus Cellular Receptor 2 Market The global Hepatitis A Virus Cellular Receptor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis A Virus Cellular Receptor 2 S…
- B型肝炎検査の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis B Testing Market The global Hepatitis B Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis B Testing Scope and Market Size Hepatitis B Testing market is seg…